近日，海南海药发布公告，拟减持其持有的港股上市公司中国抗体部分股权，减持的股份数量不超过6800万股，占中国抗体总股本的比例不超过5%。海南海药目前持有中国抗体1.59亿股股份，占其总股本的11.46%。 海南海药前期大举并购、投资PE、炒股、建设大型工程项目、购买房产等一系列操作大手笔烧钱，为此后危机埋下种子。2019年至2025年，海南海药累计亏损额预计超43亿元。而其核心产品受集采、医保...
Source Link近日，海南海药发布公告，拟减持其持有的港股上市公司中国抗体部分股权，减持的股份数量不超过6800万股，占中国抗体总股本的比例不超过5%。海南海药目前持有中国抗体1.59亿股股份，占其总股本的11.46%。 海南海药前期大举并购、投资PE、炒股、建设大型工程项目、购买房产等一系列操作大手笔烧钱，为此后危机埋下种子。2019年至2025年，海南海药累计亏损额预计超43亿元。而其核心产品受集采、医保...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.